AC Immune rises as Alzheimer vaccine set for development

AC Immune AG

30/11/2022 13:37

** Shares of AC Immune SA  ACIU.O  jump 4.6% to $2.74 before
the bell
    ** The drug developer said its experimental Alzheimer
vaccine developed in collaboration with Johnson & Johnson's unit
has been selected for further development  urn:newsml:reuters.com:*:nGNX8bbLKy
    ** The decision is based on data from early-to-mid stage
study that showed efficacy and safety of the vaccine
    ** Up to Tuesday's close, stock down ~47% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))